|
|
|
Volumn 45, Issue 1, 2002, Pages 18-24
|
|
Formulations and related activities for the oral administration of poorly water-soluble compounds in early discovery animal studies: An overview of frequently applied approaches
a
|
|
Author keywords
Bioavailability, oral; Drug discovery; Drug solubility; Exploratory drug formulations; Prodrugs; Salts (of drugs)
|
|
Indexed keywords
2 HYDROXYPROPYL BETA CYCLODEXTRIN;
4,7 DIBENZYL 2,3,4,5,6,7 HEXAHYDRO 5,6 DIHYDROXY 1,3 BIS[4 (HYDROXYMETHYL)BENZYL] 2H 1,3 DIAZEPIN 2 ONE;
ACYLGLYCEROL;
CARBOXYMETHYLCELLULOSE;
CREMOPHOR;
DANAZOL;
DMP 565;
DRUG SOLVENT;
DRUG VEHICLE;
GELUCIRE;
HALOFANTRINE;
HYPOCHOLESTEROLEMIC AGENT;
INTRALIPID;
MACROGOL;
MACROGOL 400;
METHYLCELLULOSE;
OIL;
POLOXAMER;
POVIDONE;
PRODRUG;
PROPYLENE GLYCOL;
PROTEINASE INHIBITOR;
SAFFLOWER OIL;
SOLUTOL HS 15;
STEROL DERIVATIVE;
SURFACTANT;
TA 7552;
TOCOFERSOLAN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
XENOBIOTIC AGENT;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG RESEARCH;
DRUG SOLUBILITY;
NONHUMAN;
PHARMACODYNAMICS;
REVIEW;
|
|
EID: 0036203506
PISSN: 00126683
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
